JP2021525246A5 - - Google Patents
Info
- Publication number
- JP2021525246A5 JP2021525246A5 JP2020565348A JP2020565348A JP2021525246A5 JP 2021525246 A5 JP2021525246 A5 JP 2021525246A5 JP 2020565348 A JP2020565348 A JP 2020565348A JP 2020565348 A JP2020565348 A JP 2020565348A JP 2021525246 A5 JP2021525246 A5 JP 2021525246A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- peptide
- ctp
- items
- xaa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862675307P | 2018-05-23 | 2018-05-23 | |
| US62/675,307 | 2018-05-23 | ||
| US201862778033P | 2018-12-11 | 2018-12-11 | |
| US62/778,033 | 2018-12-11 | ||
| US201962811077P | 2019-02-27 | 2019-02-27 | |
| US62/811,077 | 2019-02-27 | ||
| PCT/US2019/033551 WO2019226785A1 (en) | 2018-05-23 | 2019-05-22 | Cardiac-specific targeting-peptide (ctp), compositions, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021525246A JP2021525246A (ja) | 2021-09-24 |
| JP2021525246A5 true JP2021525246A5 (https=) | 2022-05-31 |
Family
ID=68617073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565348A Pending JP2021525246A (ja) | 2018-05-23 | 2019-05-22 | 心臓特異的標的化ペプチド（ｃｔｐ）、組成物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210206805A1 (https=) |
| EP (1) | EP3811451A4 (https=) |
| JP (1) | JP2021525246A (https=) |
| KR (1) | KR20210022575A (https=) |
| CN (1) | CN112512546A (https=) |
| AU (1) | AU2019275044B2 (https=) |
| CA (1) | CA3100943A1 (https=) |
| WO (1) | WO2019226785A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020210712A2 (en) | 2019-04-10 | 2020-10-15 | Coralluma Llc. | Ir700 nanocompositions for cardiac therapies and applications |
| WO2021087037A1 (en) * | 2019-10-29 | 2021-05-06 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Lung-specific targeting-peptide (ltp), compositions, and uses thereof |
| EP4531869A2 (en) * | 2022-05-31 | 2025-04-09 | Georgetown University | Use of conjugates of microrna and cardiac targeting peptides for treating heart failure |
| AU2024314139A1 (en) | 2023-06-20 | 2026-01-08 | Kuva Labs Inc. | Methods for magnetic resonance molecular imaging of nanoconstructs and uses thereof |
| ES2953301B2 (es) * | 2023-09-25 | 2024-06-03 | Univ Madrid Complutense | Péptido para el tratamiento de enfermedades cardiacas |
| WO2025106145A1 (en) * | 2023-11-13 | 2025-05-22 | Mayo Foundation For Medical Education And Research | Hybrid form of cardiac targeting peptide with increased serum stability and enhanced cardiomyocyte targeting |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063576A (en) * | 1998-06-29 | 2000-05-16 | University Of Utah Research Foundation | Actin mutations in dilated cardiomyopathy, a heritable form of heart failure |
| EP2316468A1 (en) * | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| RS91004A (sr) * | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Postupci za lečenje ileusa |
| JP2007505158A (ja) * | 2003-05-21 | 2007-03-08 | ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム | 心肥大および心不全の処置としてのプロテインキナーゼＣ−μ（ＰＫＤ）の阻害 |
| US8460658B2 (en) * | 2003-10-10 | 2013-06-11 | Alchemia Oncology Pty Limited | Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| WO2010033868A2 (en) * | 2008-09-19 | 2010-03-25 | Taligen Therapeutics, Inc. | Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof |
| AU2010305284A1 (en) * | 2009-10-06 | 2012-05-03 | Angiochem Inc. | Compositions and methods for the transport of therapeutic agents |
| US9249184B2 (en) * | 2010-10-14 | 2016-02-02 | University of Pittsburgh—of the Commonwealth System of Higher Education | Cardiac-specific protein targeting domain |
| US10512691B2 (en) * | 2012-04-23 | 2019-12-24 | The Regents Of The University Of Michigan | Systems and methods for targeted imaging and ablation of cardiac cells |
| EP2928502B1 (en) * | 2012-12-05 | 2019-01-23 | Ruprecht-Karls-Universität Heidelberg | Conjugates of proteins and multivalent cell-penetrating peptides and their uses |
| WO2014093251A1 (en) * | 2012-12-10 | 2014-06-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Engineered receptors and their use |
| US9550981B2 (en) * | 2014-01-22 | 2017-01-24 | University Of Washington | Modified tafazzin proteins and methods of making and using the same |
| WO2018090042A1 (en) * | 2016-11-14 | 2018-05-17 | Renova Therapeutics, Inc. | Methods of treating heart failure |
-
2019
- 2019-05-22 US US17/056,193 patent/US20210206805A1/en not_active Abandoned
- 2019-05-22 CN CN201980049263.2A patent/CN112512546A/zh active Pending
- 2019-05-22 CA CA3100943A patent/CA3100943A1/en active Pending
- 2019-05-22 EP EP19806834.8A patent/EP3811451A4/en active Pending
- 2019-05-22 KR KR1020207036623A patent/KR20210022575A/ko not_active Ceased
- 2019-05-22 WO PCT/US2019/033551 patent/WO2019226785A1/en not_active Ceased
- 2019-05-22 AU AU2019275044A patent/AU2019275044B2/en active Active
- 2019-05-22 JP JP2020565348A patent/JP2021525246A/ja active Pending
-
2023
- 2023-04-19 US US18/303,093 patent/US20230406882A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525246A5 (https=) | ||
| DE69837809T2 (de) | Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen | |
| DE69837855T2 (de) | Apolipoprotein-a-i-agonisten und ihre anwendung zum behandeln von dyslipidämischer erkrankung | |
| KR100650975B1 (ko) | 비정상 지혈증 장애 치료용 아포리포단백질 ａ-ｉ 유사펩티드를 공급하는 유전자 치료법 | |
| DE69839014T2 (de) | Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen | |
| KR101688547B1 (ko) | 아포리포단백질 ａ-ｉ 모방체 | |
| EP3185880B1 (en) | Improved peptidyl calcineurin inhibitors | |
| US20110268768A1 (en) | Compositions and Methods for Treating Atherosclerosis | |
| JP2007518818A (ja) | 酸化的損傷を低減する方法 | |
| JP5893614B2 (ja) | アルツハイマー病および家族性認知症の治療のための化合物および方法 | |
| US20100279926A1 (en) | Compositions and Methods for Treating Atherosclerosis | |
| JP2021526505A5 (https=) | ||
| JP2012504619A (ja) | 肥満および糖尿病の有望な治療薬としてのグレリンｏ−アシルトランスフェラーゼ阻害剤の合成方法および使用方法 | |
| KR20210022575A (ko) | 심장-특이적 표적화-펩티드 (ctp), 조성물, 및 그의 용도 | |
| US20160207969A1 (en) | Clostridium difficile targeting moieties and constructs comprising said moieties | |
| US11174287B2 (en) | Central nervous system homing peptides and uses thereof | |
| JP2008502736A (ja) | 高脂血症および関連疾患の治療のための複素環式誘導体 | |
| US20220315625A1 (en) | Lung-specific targeting-peptide (ltp), compositions, and uses thereof | |
| EP4321527A1 (en) | Cell-penetrating peptide variant and use thereof | |
| US20120196789A1 (en) | Peptide based peroxidase inhibitors and methods of using same | |
| ES2387435B1 (es) | Uso de heptapéptidos para el control de la hipertensión | |
| US12409205B2 (en) | Nanomolecules for the treatment of inflammatory bowel diseases | |
| JP2015160827A (ja) | 急性腎障害に起因する多臓器不全の予防又は治療薬 | |
| JP2024536505A (ja) | ナノモル濃度で細胞内に伝達可能なミトコンドリア特異的ペプチド及びその用途 | |
| AU763679B2 (en) | Crosslink-stabilized indolicidin analogs |